Chief Executive Officer

Remote

Responsibilities

Define Strategy: Refine the companyâs scientific and corporate trajectory, ensuring an efficient path from preclinical study initiation to validated programs.
Prioritize Indications: Establish milestone-driven development plans for high-value targets (adult ADHD, depression, and anxiety) optimized for a capital-efficient seed-to-Series-A timeline.

Initially focusing on adult Attention-Deficit/Hyperactivity Disorder (ADHD), depression, and anxiety, Magdalena leverages Jaguarâs proprietary library of 2,300 highly characterized medicinal plants and Filamentâs advanced drug development technology.
The ideal candidate possesses a deep understanding of FDA botanical drug guidance, Central Nervous System (CNS) indications, and early-stage biotech operations.
experience in botanical drug development, appetite suppression, or neuropsychiatric/CNS drug pipelines.
Scientific Fluency: Ability to speak the language of science fluently and engage meaningfully with researchers, clinicians, and technical partners.
Communication: Exceptional emotional intelligence, with the ability to deliver scientifically credible and commercially sharp communications. Education
Required: Advanced background in medicine or life sciences (PhD or MD highly preferred; equivalent industry tenure considered).
Preferred: MBA or equivalent business credential. Why Join Us?
This is a beta feature to avoid spam applicants.

Clinical Meaning: Transform the landscape of mental health care by delivering a safer, natural class of prescription medicines to patients in need.
Compensation Package â Competitive with an early-stage CEO pay package including base salary, bonus and equity *

Company Stage: Seed Stage (Preparing for Series A)
Magdalena Biosciences is a pioneering joint venture formed by Jaguar Health and Filament Health, with foundational funding from One Small Planet.
We are uniquely positioned to build revolutionary drugs from whole-extract coca leaf, offering safe, novel mechanisms of action compared to chemically synthesized small-molecule drugs. Position Overview
Magdalena Biosciences is seeking a highly entrepreneurial and visionary Chief Executive Officer (CEO) to lead the company through its seed expansion, drive early pipeline development, and secure a successful Series A financing round.
Operating in a lean, resource-constrained environment, you will drive strategic clarity from ambiguity, turning raw botanical innovation into a validated, commercializable clinical pipeline. Key Responsibilities
Risk Mitigation: Proactively identify and derisk scientific, regulatory, and operational assumptions early in the development lifecycle.
Capital Acquisition: Lead all financing activities, maximizing seed expansion and driving the strategy for a successful Series A raise.
Relationship Management: Build and maintain high-trust relationships with venture capitalists, impact investors, and strategic partners.
Corporate Narrative: Craft and articulate a compelling, scientifically credible company narrative to external stakeholders.
Recruitment: Build and lead a lean, elite, cross-functional team across R&D, clinical operations, and program management.